Sign in to NCBI
Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Radical Chemistry and Cytotoxicity of Bioreductive 3-Substituted Quinoxaline Di-N-Oxides.

Anderson RF, Yadav P, Shinde SS, Hong CR, Pullen SM, Reynisson J, Wilson WR, Hay MP.

Chem Res Toxicol. 2016 Aug 15;29(8):1310-24. doi: 10.1021/acs.chemrestox.6b00133. Epub 2016 Jul 29.

PMID:
27380897

Similar articles

2.

Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma.

Abbattista MR, Jamieson SM, Gu Y, Nickel JE, Pullen SM, Patterson AV, Wilson WR, Guise CP.

Cancer Biol Ther. 2015;16(4):610-22. doi: 10.1080/15384047.2015.1017171. Epub 2015 Apr 14.

PMID:
25869917
Free PMC Article

Similar articles

3.

Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancer.

Hunter FW, Hsu HL, Su J, Pullen SM, Wilson WR, Wang J.

Mol Cancer Ther. 2014 Nov;13(11):2501-14. doi: 10.1158/1535-7163.MCT-14-0476. Epub 2014 Sep 5.

PMID:
25193512
Free Article

Similar articles

4.

A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells.

Jamieson SM, Gu Y, Manesh DM, El-Hoss J, Jing D, Mackenzie KL, Guise CP, Foehrenbacher A, Pullen SM, Benito J, Smaill JB, Patterson AV, Mulaw MA, Konopleva M, Bohlander SK, Lock RB, Wilson WR.

Biochem Pharmacol. 2014 Mar 1;88(1):36-45. doi: 10.1016/j.bcp.2013.12.019. Epub 2014 Jan 13.

PMID:
24434189

Similar articles

5.

DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity.

Singleton RS, Guise CP, Ferry DM, Pullen SM, Dorie MJ, Brown JM, Patterson AV, Wilson WR.

Cancer Res. 2009 May 1;69(9):3884-91. doi: 10.1158/0008-5472.CAN-08-4023. Epub 2009 Apr 14.

PMID:
19366798
Free Article

Similar articles

6.

Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.

Patterson AV, Ferry DM, Edmunds SJ, Gu Y, Singleton RS, Patel K, Pullen SM, Hicks KO, Syddall SP, Atwell GJ, Yang S, Denny WA, Wilson WR.

Clin Cancer Res. 2007 Jul 1;13(13):3922-32.

PMID:
17606726
Free Article

Similar articles

7.

Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards.

Wilson WR, Hicks KO, Pullen SM, Ferry DM, Helsby NA, Patterson AV.

Radiat Res. 2007 Jun;167(6):625-36.

PMID:
17523848

Similar articles

8.

Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.

Atwell GJ, Yang S, Pruijn FB, Pullen SM, Hogg A, Patterson AV, Wilson WR, Denny WA.

J Med Chem. 2007 Mar 22;50(6):1197-212. Epub 2007 Feb 28.

PMID:
17326614

Similar articles

9.

Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.

Helsby NA, Atwell GJ, Yang S, Palmer BD, Anderson RF, Pullen SM, Ferry DM, Hogg A, Wilson WR, Denny WA.

J Med Chem. 2004 Jun 3;47(12):3295-307.

PMID:
15163209

Similar articles

10.

2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.

Helsby NA, Ferry DM, Patterson AV, Pullen SM, Wilson WR.

Br J Cancer. 2004 Mar 8;90(5):1084-92.

PMID:
14997211
Free PMC Article

Similar articles

11.

In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.

Wilson WR, Pullen SM, Hogg A, Hobbs SM, Pruijn FB, Hicks KO.

Methods Mol Med. 2004;90:403-31. No abstract available.

PMID:
14657576

Similar articles

12.

Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.

Hay MP, Atwell GJ, Wilson WR, Pullen SM, Denny WA.

J Med Chem. 2003 Jun 5;46(12):2456-66.

PMID:
12773049

Similar articles

13.

Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.

Tercel M, Stribbling SM, Sheppard H, Siim BG, Wu K, Pullen SM, Botting KJ, Wilson WR, Denny WA.

J Med Chem. 2003 May 22;46(11):2132-51.

PMID:
12747786

Similar articles

14.

Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.

Wilson WR, Pullen SM, Hogg A, Helsby NA, Hicks KO, Denny WA.

Cancer Res. 2002 Mar 1;62(5):1425-32.

PMID:
11888915
Free Article

Similar articles

15.

Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.

Siim BG, Hicks KO, Pullen SM, van Zijl PL, Denny WA, Wilson WR.

Biochem Pharmacol. 2000 Oct 1;60(7):969-78.

PMID:
10974206

Similar articles

16.

Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.

Siim BG, Atwell GJ, Anderson RF, Wardman P, Pullen SM, Wilson WR, Denny WA.

J Med Chem. 1997 Apr 25;40(9):1381-90.

PMID:
9135035

Similar articles

17.

Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase.

Atwell GJ, Boyd M, Palmer BD, Anderson RF, Pullen SM, Wilson WR, Denny WA.

Anticancer Drug Des. 1996 Oct;11(7):553-67.

PMID:
8921936

Similar articles

18.

Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.

Wilson WR, Denny WA, Pullen SM, Thompson KM, Li AE, Patterson LH, Lee HH.

Br J Cancer Suppl. 1996 Jul;27:S43-7.

PMID:
8763844
Free PMC Article

Similar articles

19.

Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.

Lee HH, Wilson WR, Ferry DM, van Zijl P, Pullen SM, Denny WA.

J Med Chem. 1996 Jun 21;39(13):2508-17.

PMID:
8691448

Similar articles

20.

Acquisition of prototype-based information about social groups in adulthood.

Hess TM, Pullen SM, McGee KA.

Psychol Aging. 1996 Mar;11(1):179-90.

PMID:
8726383

Similar articles

21.

Adult age differences in impression change processes.

Hess TM, Pullen SM.

Psychol Aging. 1994 Jun;9(2):237-50.

PMID:
8054172

Similar articles

22.

Nitrobenzyl mustard quaternary salts: a new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction.

Denny WA, Wilson WR, Tercel M, Van Zijl P, Pullen SM.

Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):317-21.

PMID:
8195026

Similar articles

23.

Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.

Palmer BD, Wilson WR, Pullen SM, Denny WA.

J Med Chem. 1990 Jan;33(1):112-21.

PMID:
2296009

Similar articles

Supplemental Content

Filters: Manage Filters

Loading ...
You are here: NCBI > Literature > PubMed
Support Center